Chemomab Therapeutics Ltd DRC
Price & Volume
Stats
See more52W Range | $1.05-$3.49 |
Market Cap | $10.1M |
Shares Short | 10,544 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.04 |
News
See moreYahoo Finance • last month
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
Yahoo Finance • 3 months ago
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
Yahoo Finance • 7 months ago
Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update
About
CEO | Dr. Adi Mor George Ph.D. |
Address | Building C, Tel Aviv-Yafo, Israel, 6158101 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |